Bumper Offer - Urjas oil Just @ Rs. 1
Rocef (Glenmark) is a prescription medicine that is available as a Injection. Urinary Tract Infection, Gonorrhea, Meningitis are some of its major therapeutic uses. Other than this, Rocef (Glenmark) has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Rocef (Glenmark). Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Rocef (Glenmark) have been listed ahead. Normally, these side effects of Rocef (Glenmark) are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Rocef (Glenmark) is Safe for pregnant women and Mild for women who are breastfeeding. In addition, Rocef (Glenmark)'s effects on the liver, heart and kidney are discussed below in the Rocef (Glenmark) related warnings section.
Rocef (Glenmark) is contraindicated in people with pre-existing medical conditions like Jaundice, Drug Allergy as it can result in adverse effects. Other conditions have been mentioned below in the Rocef (Glenmark) contraindications section.
Besides this, Rocef (Glenmark) may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Rocef (Glenmark) is not safe while driving, and is not addiction.
Rocef (Glenmark) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Rocef (Glenmark) safe for pregnant women?
Pregnant women can take Rocef (Glenmark) without worrying about any side effects.
Is the use of Rocef (Glenmark) safe during breastfeeding?
Breastfeeding women can take Rocef (Glenmark) as it bears very minor side effects for them.
What is the effect of Rocef (Glenmark) on the Kidneys?
Rocef (Glenmark) has very mild side effects on the kidneys.
What is the effect of Rocef (Glenmark) on the Liver?
Rocef (Glenmark) has very mild side effects on the liver.
What is the effect of Rocef (Glenmark) on the Heart?
There are no any side effects of Rocef (Glenmark) for the heart.
Rocef (Glenmark) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Rocef (Glenmark) unless your doctor advises you to do so -
Is this Rocef (Glenmark) habit forming or addictive?
No, there is no any evidence that Rocef (Glenmark) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rocef (Glenmark) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Rocef (Glenmark) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Rocef (Glenmark) in mental disorders is not effective.
Interaction between Food and Rocef (Glenmark)
You can take Rocef (Glenmark) with food.
Interaction between Alcohol and Rocef (Glenmark)
Due to lack of research, there is no information about the side effects of taking Rocef (Glenmark) with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftriaxone
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727-728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311